TABLE 1.
Phospho-peptides.
| W/o phosphatase treatment | With phosphatase treatment | Total phospho-sites | % | |
|---|---|---|---|---|
| Total phospho-peptides | 99 | 158 | 257 | |
| Consensus site for CK1 | ||||
| Canonical sites | 42 | 84 | 126 | 72 |
| Non-canonical sites | 31 | 43 | 74 | |
| Others sites | 31 | 46 | 77 | 28 |
| Sites phosphorylated by huCK1s | ||||
| Site phosphorylated in vitro | 14 | 9 | 19 | 7 |
| Sites detected in human cell phospho-proteomes | ||||
| Site phosphorylated in vivo | 92 | 149 | 241 | 94 |
| SARS-coV2 infection | ||||
| Sites phosphorylated during SARS-coV2 infection | 20 | 28 | 52 | 20 |
| Tumorigenesis | ||||
| Site phosphorylated in cancer cells | 83 | 146 | 229 | 89 |
| Sites mutated during tumorigenesis | 10 | 16 | 26 | 10 |